You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Serotonin Syndrome

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Fibrosis in Chronic and Delayed Myocardial Infarction

Recruiting
  • Aortic Stenosis
  • +2 more
  • 68Ga-FAPI and 18F-AlF-FAPI PET-MR
  • Edinburgh, Scotland, United Kingdom
    University of Edinburgh
Mar 1, 2023

Neuroendocrine Tumors, Carcinoid Tumor of GI System, Diarrhea Trial in Lexington (Amino Acid Based Medical Food/Drink)

Completed
  • Neuroendocrine Tumors
  • +3 more
  • Amino Acid Based Medical Food/Drink
  • Lexington, Kentucky
    University of Kentucky Markey Cancer Center
Nov 2, 2022

Carcinoid Syndrome, Carcinoid, Carcinoid Tumor Trial in Newport Beach, Lexington, Stony Brook (Randomized: 40 mg Paltusotine,

Recruiting
  • Carcinoid Syndrome
  • +8 more
  • Randomized: 40 mg Paltusotine
  • Randomized: 80 mg Paltusotine
  • Newport Beach, California
  • +5 more
Jan 3, 2023

Carcinoid Syndrome Trial in Research Triangle Park (Xermelo)

Completed
  • Carcinoid Syndrome
  • Research Triangle Park, North Carolina
    RTI-HS
Jan 18, 2022

Tourette Disorder Trial in Bron, Paris (Administration of a PET radiotracer)

Not yet recruiting
  • Tourette Disorder
  • Administration of a PET radiotracer
  • Bron, France
  • +1 more
Jul 12, 2023

Neuroendocrine Tumors, Carcinoid Syndrome, Diarrhea Trial in Iowa City (Telotristat ethyl, Peptide Receptor Radionuclide

Withdrawn
  • Neuroendocrine Tumors
  • +2 more
  • Telotristat ethyl
  • +2 more
  • Iowa City, Iowa
    University of Iowa Hospital and Clinics
Feb 9, 2022

Tricuspid Regurgitation, Tricuspid Valve Disease, Carcinoid Syndrome Trial in London (Transcatheter Tricuspid Valved Stent

Not yet recruiting
  • Tricuspid Regurgitation
  • +3 more
  • Transcatheter Tricuspid Valved Stent Graft
  • London, England, United Kingdom
    Barts Health NHS Trust
Apr 19, 2022

Advanced Neuroendocrine Tumor, Carcinoid Syndrome Trial (Retifanlimab, Telotristat Ethyl)

Withdrawn
  • Advanced Neuroendocrine Neoplasm
  • Carcinoid Syndrome
  • Retifanlimab
  • Telotristat Ethyl
  • (no location specified)
Sep 23, 2021

Viral Pneumonia, COVID-19 Pneumonia, Serotonin Syndrome Trial (Cyproheptadine Hydrochloride 4 MG)

Not yet recruiting
  • Viral Pneumonia
  • +3 more
  • Cyproheptadine Hydrochloride 4 MG
  • (no location specified)
May 5, 2021

Viral Pneumonia, Serotonin Syndrome, Platelet Dysfunction Trial (Cyproheptadine Hydrochloride 4 MG)

Not yet recruiting
  • Viral Pneumonia
  • +2 more
  • Cyproheptadine Hydrochloride 4 MG
  • (no location specified)
Mar 31, 2021

Carcinoid Syndrome, Metastatic Nonfunctional Well Differentiated Neuroendocrine Tumor Trial in Detroit (other, procedure, drug)

Recruiting
  • Carcinoid Syndrome
  • Metastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm
  • Carbon C 11 Alpha-methyltryptophan
  • +3 more
  • Detroit, Michigan
    Wayne State University/Karmanos Cancer Institute
Mar 30, 2022

Carcinoid Syndrome, Carcinoid Tumor, Digestive System Neuroendocrine Tumor G1 Trial in Houston (Dual-Energy Computed Tomography)

Recruiting
  • Carcinoid Syndrome
  • +3 more
  • Dual-Energy Computed Tomography
  • Houston, Texas
    M D Anderson Cancer Center
Jul 28, 2021

Neurodevelopmental Disorders, Autism, Autism Spectrum Disorder Trial in Canada (Sertraline, Placebo)

Not yet recruiting
  • Neurodevelopmental Disorders
  • +25 more
  • Calgary, Alberta, Canada
  • +6 more
Oct 11, 2023

Neuroendocrine Tumor, Carcinoid Syndrome Trial in Nashville (Enterade®, Functional Assessment of Chronic Illness Therapy for

Terminated
  • Neuroendocrine Tumor
  • Carcinoid Syndrome
  • Enterade®
  • Functional Assessment of Chronic Illness Therapy for Patients with Diarrhea (version 4.0)
  • Nashville, Tennessee
    Vanderbilt-Ingram Cancer Center
May 18, 2021

Carcinoid Syndrome Trial in Worldwide (Lanreotide, Placebo)

Completed
Has Results
  • Carcinoid Syndrome
  • Los Angeles, California
  • +53 more
Sep 15, 2022

Carcinoid Heart Disease, Carcinoid Syndrome, Carcinoid Tumor Trial (Lutathera)

Not yet recruiting
  • Carcinoid Heart Disease
  • +2 more
  • (no location specified)
Aug 3, 2020

Baby Detect : Genomic Newborn Screening

Recruiting
  • Congenital Adrenal Hyperplasia
  • +126 more
    • Liege, Wallonia, Belgium
      CRMN, Hôpital La Citadelle
    Jan 24, 2023

    Smoking Trial in Incheon (group counseling, Auricular acupressure, acupressure)

    Terminated
    • Smoking
    • group counseling
    • +2 more
    • Incheon, Korea, Republic of
      Inha University Hospital
    Feb 8, 2021

    Peripheral Serotonin and Albinism

    Not yet recruiting
    • Oculocutaneous Albinism
    • Dosage of serotonin and metabolites
    • Blood parameters
    • Paris, France
      Hôpital Necker-Enfants Malades
    Nov 14, 2023

    Malignant Carcinoid Syndrome Trial in Tampa (lanreotide Autogel (somatostatin analogue), Sandostatin long acting release (LAR)

    Terminated
    • Malignant Carcinoid Syndrome
    • lanreotide Autogel (somatostatin analogue)
    • Sandostatin long acting release (LAR) Depot (somatostatin analogue)
    • Tampa, Florida
      Larry Kvols, MD
    Apr 28, 2020

    Myofascial Pain, Temporomandibular Disorders Trial in Huddinge (Granisetron, Control ())

    Completed
    • Myofascial Pain
    • Temporomandibular Disorders
    • Huddinge, Sweden
      Karolinska Institutet, Department of Dental Medicine
    Mar 23, 2021

    Small Intestinal NET, Carcinoid Heart Disease Trial (Telotristat Ethyl, Lanreotide)

    Withdrawn
    • Small Intestinal NET
    • Carcinoid Heart Disease
    • (no location specified)
    Jan 30, 2020

    DaTSCAN Brain Scintigraphy and Psychotropic Treatments:

    Not yet recruiting
    • Parkinson Disease
    • scintigraphy DaTSCAN
    • Vandœuvre-lès-Nancy, France
      CHRU Nancy
    Jan 5, 2023

    Neuroendocrine Tumors, Carcinoid Syndrome Trial (Sandostatin)

    Terminated
    • Neuroendocrine Tumors
    • Carcinoid Syndrome
    • (no location specified)
    Oct 24, 2019

    Fragile X Syndrome, Behavior, Cognitive Dysfunction Trial in London (Psilocybin, 1.5 mg)

    Recruiting
    • Fragile X Syndrome
    • +2 more
    • Psilocybin, 1.5 mg
    • London, Ontario, Canada
      KGK Science Inc.
    Apr 14, 2023